Comparative Pharmacology
Head-to-head clinical analysis: COR OTICIN versus FLUONID.
Peer-Reviewed Evidence
Head-to-head clinical analysis: COR OTICIN versus FLUONID.
COR-OTICIN vs FLUONID
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
COR-OTICIN is a combination product containing hydrocortisone (a corticosteroid with anti-inflammatory and immunosuppressive properties) and neomycin (an aminoglycoside antibiotic that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit) and polymyxin B (a polymyxin antibiotic that disrupts bacterial cell membrane permeability).
Fluocinolone acetonide is a corticosteroid that binds to the glucocorticoid receptor, leading to inhibition of phospholipase A2, reduction of prostaglandin and leukotriene synthesis, and suppression of inflammatory mediators.
1-2 drops in each affected ear twice daily for 7 days.
0.05% cream or ointment applied topically to affected area once daily. Not to exceed 30 g per week.
None Documented
None Documented
Terminal half-life 4-6 hours; prolonged in renal impairment (up to 12-15 hours)
3.5 hours; prolonged to 18–24 hours in severe hepatic impairment.
Renal (60-80% unchanged), fecal/biliary (5-10%)
Renal 70% as unchanged drug, biliary/fecal 30% as metabolites.
Category C
Category C
Topical Corticosteroid + Antibiotic
Topical Corticosteroid